Cannabis Testing Market, By Product (Instruments, Consumables, LIMS) Services (Heavy Metal Testing, Microbial Analysis, Potency, Residual Screening), End-User (Cultivators, Laboratories, Research Institutes) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa and South America)
Global Cannabis Testing Market is anticipated to reach USD 967.5 million in 2021 growing at a CAGR of 13.9% during the forecasting period, 2021-2028.
Cannabinoids are a class of chemicals derived from the plants belonging to the cannabis genus primarily Cannabis Sativa. For the extraction of the pure cannabinoid from the chemicals in the plant 4 steps are followed. The steps are 1. Solid/liquid extraction 2. Winterisation 3. Filtration 4. Dry down. After following the steps pure cannabinoids are obtained as a dry powder. Cannabis is known to have a profound effect on the brain and CNS by binding to receptors there. The main chemical compound that binds to the receptors is tetrahydrocannabinol. These are given in the case of surgery or conditions of extreme pain to the patients.
With the surge in laboratories researches for cannabis testing and integration of LIMS (laboratory information management system) along with increased recognition and medical legalization of cannabis are some of the factors that have supported long-term expansion for the cannabis testing industry.
Global Cannabis Testing Market is segmented into product, services, end-user, and geography.
Product segment is segmented into Instruments, Consumables, and LIMS
Services segment is segmented into Heavy Metal Testing, Microbial Analysis, Potency, and Residual Screening
End-User segment is segmented into Cultivators, Laboratories, and Research Institutes
Geographically, the global Cannabis Testing Market is sub-segmented into North America, Europe, Asia-Pacific, Middle East and Africa and South America and insights are provided for each region and major countries within the regions
Key players in global Cannabis Testing Agilent Technologies, Inc. (US), Shimadzu Corporation (Japan), MERCK KGAA (Germany), Thermo Fisher Scientific (US), DigiPath, Inc. (US), Steep Hill Inc. (US), SC Laboratories, Inc. (US), and PharmLabs LLC (US) others.
Report Feature |
Descriptions |
---|---|
Market Revenue In 2021 |
USD 967.5 million |
Growth Rate |
CAGR of 13.7% during the forecasting period, 2021-2028 |
Historical Data |
2018-2019 |
Forecast Years |
2021-2028 |
Base Year |
2020 |
Units Considered |
Revenue in USD million and CAGR from 2021 to 2028 |
Report Segmentation |
Product, Application, End-User, and Geography |
Report Attribute |
Market Revenue Sizing (Global, Regional and Country Level) Company Share Analysis, Market Dynamics, Company Profiling |
Regional Level Scope |
North America, Europe, Asia-Pacific, South America, and the Middle East and Africa |
Country Level Scope |
U.S., Japan, Germany, U.K., China, India, Brazil, UAE, South Africa (50+ Countries Across the Globe) |
Companies Profiled |
Agilent Technologies, Inc. (US), Shimadzu Corporation (Japan), MERCK KGAA (Germany), Thermo Fisher Scientific (US), DigiPath, Inc. (US), Steep Hill Inc. (US), SC Laboratories, Inc. (US), and PharmLabs LLC (US). |
Available Customization |
In addition to the market data for Global Cannabis Testing Market, Delvens offers client-centric reports and customized according to the company’s specific demand and requirement. |